Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REMIFENTANIL vs REPAGLINIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REMIFENTANIL vs REPAGLINIDE: Safety Overview

Metric REMIFENTANIL REPAGLINIDE
Total FAERS Reports 2,733 2,544
Deaths Reported 210 169
Death Rate 7.7% 6.6%
Hospitalizations 995 1,517
Average Patient Age 50.3 yrs 71.9 yrs
% Female Patients 48.2% 45.5%
FDA Approval Date Jan 16, 2018 Apr 24, 2015
Manufacturer Fresenius Kabi USA, LLC Rising Pharma Holdings, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued